DRZID
BMY icon

DePrince Race & Zollo Inc (DRZ)’s Bristol-Myers Squibb BMY Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-506,054
Closed -$29.4M – 180
2023
Q3 		$29.4M Buy
506,054
+41,361
+9% +$2.53M 0.71% 52
2023
Q2 		$29.7M Buy
464,693
+104,879
+29% +$7.03M 0.68% 53
2023
Q1 		$24.9M Sell
359,814
-5,081
-1% -$358K 0.58% 77
2022
Q4 		$26.3M Sell
364,895
-40,447
-10% -$3.05M 0.6% 82
2022
Q3 		$28.8M Buy
405,342
+1,903
+0.5% +$138K 0.74% 57
2022
Q2 		$31.1M Sell
403,439
-112,507
-22% -$8.57M 0.72% 62
2022
Q1 		$37.7M Sell
515,946
-75,386
-13% -$5.06M 0.73% 55
2021
Q4 		$36.9M Buy
591,332
+118,081
+25% +$6.93M 0.94% 28
2021
Q3 		$28M Sell
473,251
-8,475
-2% -$558K 0.75% 49
2021
Q2 		$32.2M Buy
481,726
+11,827
+3% +$771K 0.81% 29
2021
Q1 		$29.7M Buy
469,899
+86,204
+22% +$5.36M 0.8% 33
2020
Q4 		$23.8M Buy
383,695
+54,657
+17% +$3.36M 0.75% 38
2020
Q3 		$19.8M Buy
329,038
+64,453
+24% +$3.88M 0.74% 42
2020
Q2 		$15.6M Sell
264,585
-53,168
-17% -$3.18M 0.6% 67
2020
Q1 		$17.7M Sell
317,753
-62,545
-16% -$3.82M 0.81% 39
2019
Q4 		$24.4M Sell
380,298
-144,544
-28% -$8.28M 0.74% 45
2019
Q3 		$26.6M Buy
524,842
+47,721
+10% +$2.24M 0.77% 43
2019
Q2 		$21.6M Buy
477,121
+56,756
+14% +$2.64M 0.6% 70
2019
Q1 		$20.1M Buy
+420,365
New +$20.9M 0.55% 82

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s BMY Position: Q4 2023 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 506,054 shares — an estimated $29.4M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in BMY in Q1 2019 and held it in 19 quarters. The position peaked at $37.7M in Q1 2022. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 506,054 Bristol-Myers Squibb shares in Q4 2023, an estimated $29.4M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 19 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s Bristol-Myers Squibb position peaked at $37.7M in Q1 2022.
  • 2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q4 2023, filed 14 Feb 2024.